ZD1839 (Iressa™) In Combination With Docetaxel As First-Line Treatment In Patients With Metastatic Breast Cancer
Clinical trial NCT00247481 · COMPLETED
Trial details
- NCT number
- NCT00247481
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-01
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.